Author:
Jingu K.,Umezawa R.,Yamamoto T.,Ishikawa Y.,Takahashi N.,Takeda K.,Suzuki Y.,Teramura S.,Omata S.
Publisher
Japan Broncho-Esophagological Society
Reference27 articles.
1. 1) Sjoquist KM, Burmeister BH, Smithers BM, et al: Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12: 681-692, 2011.
2. 2) Ando N, Kato H, Igaki H, et al: A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19: 68-74, 2012.
3. 3) Markar S, Gronnier C, Duhamel A, et al: Salvage surgery after chemoradiotherapy in the management of esophageal cancer: Is it a viable therapeutic option? J Clin Oncol 33: 3866-3873, 2015.
4. 4) Ariga H, Nemoto K, Miyazaki S, et al: Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75: 348-356, 2009.
5. 5) Ariga H, Ogawa Y, Nemoto K, et al: Long-term quality of life after surgical or non-surgical treatment of patients with resectable esophageal squamous cell carcinoma. Radiother Oncol 96: S283, 2010.